Insight

Samuel Blackman shares the Day One journey to reshape pediatric cancer drug development – Day One Biopharmaceuticals

Photo of Samuel Blackman taken from Day One Biopharmaceuticals/LinkedIn

Feb 26, 2024, 11:23

Samuel Blackman shares the Day One journey to reshape pediatric cancer drug development – Day One Biopharmaceuticals

Day One Biopharmaceuticals shared on their LinkedIn:

“Head of R&D and co-founder Samuel Blackman shares the Day One journey to reshape pediatric cancer drug development in this article for the Pediatric Cancer Research Foundation’s Profectus blog, Turning ‘One Day’ into ‘Day One’.”

Proceed to the article.
Source: Day One Biopharmaceuticals/LinkedIn

cancer Cancer Drug Development Day One Biopharmaceuticals OncoDaily Oncology Pediatric cancer Pediatric Cancer Research Foundation Profectus blog Samuel Blackman Turning 'One Day' into 'Day One'

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage